The function and clinical implication of YTHDF1 in the human system development and cancer

Biomarker Research

Review

Wenjun Ren¹  Yongwu Li¹  Jun Peng¹  Yixiao Yuan²  Xiulin Jiang³  Luciano Mutti⁴ 

[1] Department of Cardiovascular Surgery, The First People’s Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China;Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;Kunming College of Life Science, University of Chinese Academy of Sciences, 100049, Beijing, China;Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, 19122, Philadelphia, PA, USA;Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100, L’Aquila, Via Vetoio, Coppito 2, Italy;

关键词: YTHDF1;    Embryonic development;    Stem cell;    Self-renewal;    Tumor;    Biomarker;   

DOI  :  10.1186/s40364-023-00452-1

 received in 2022-09-28, accepted in 2022-11-26,  发布年份 2022

来源: Springer

【 摘 要 】

YTHDF1 is a well-characterized m6A reader protein that is essential for protein translation, stem cell self-renewal, and embryonic development. YTHDF1 regulates target gene expression by diverse molecular mechanisms, such as promoting protein translation or modulating the stability of mRNA. The cellular levels of YTHDF1 are precisely regulated by a complicated transcriptional, post-transcriptional, and post-translational network. Very solid evidence supports the pivotal role of YTHDF1 in embryonic development and human cancer progression. In this review, we discuss how YTHDF1 influences both the physiological and pathological biology of the central nervous, reproductive and immune systems. Therefore we focus on some relevant aspects of the regulatory role played by YTHDF1 as gene expression, complex cell networking: stem cell self-renewal, embryonic development, and human cancers progression. We propose that YTHDF1 is a promising future cancer biomarker for detection, progression, and prognosis. Targeting YTHDF1 holds therapeutic potential, as the overexpression of YTHDF1 is associated with tumor resistance to chemotherapy and immunotherapy.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

41116_2022_35_Article_IEq131.gif

Fig. 23

Fig. 20

Fig. 2

41116_2022_35_Article_IEq118.gif

Fig. 5